Week 11 - Endocrine - Diabetes Flashcards
Insulin decreases blood glucose by?
- Increasing glucose uptake into muscle and fat via GLUT-4 receptors
- Increasing glycogen synthesis
- Decreasing gluconeogenesis
- Decreasing glycogen breakdown
How is insulin released?
- B-Cell
- ATP blocks K-channel
- Depolarised cell opens Ca channel
- Ca influx contracts myosin filaments
- Insulin released
What is the percentage cause, onset and requirement of Type I diabetes?
- 5-10%
- early loss of insulin-producing pancreatic B-Cells
- Juvenille onset
- Requires insulin replacement (insulin dependant)
What is the percentage, cause, onset and requirement of Type II diabetes?
- 90-95%
- Mainly from lifestyle factors
- Adult onset
- Cellular insulin resistance
- Impaired insulin secretion
What are some Secondary Complications of Diabetes?
- Vascular disease
- Altered cardiac metabolism
- Nerve damage
- Renal Failure
- Blindness
Why are hypoglycaemic drugs usefuly for Type II and not Type I diabetes?
-Because they enhance insulin production and Type I don’t produce insulin at all.
What are some types of Hypoglycaemic drugs?
Biguanides
Sulfonylureas
Thiazolidinediones
What are the effects of Biguanides and an example?
-Increase glucose uptake in skeletal muscle
-Inhibit hepatic glucose output
-Inhibit intestinal glucose absorption
Eg Metformin
What are the effects of Sulfonylureas and an example?
Stimulate insulin secretion
-K/ATP channels contain receptors for sulfonylureas
-Only effective if pancreatic β cells are functional
Eg Tolbutamide
What are the effects of Thiazolidinediones and an example?
-Enhance effectiveness of endogenous insulin -Increase insulin sensitivity
Eg. Rosiglitazone
What are the indications for Insulin?
- Type 1 diabetes
- Type 2 - poorly managed or under stress from injury or illness
- Emergency treatment of diabetic ketoacidosis and hyperkalaemia (K moves into cell with glucose)
- Pregnancy if diet not working.
What are the uses of Glucagon?
Injection to treat hypoglaecemic episodes
Treat cardiac failure from B-adrenoceptor agonists